Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dolly osteoarthritis concerns ‘unfounded’, study concludes
The researchers performed a radiographic assessment on the skeletons of Dolly and her contemporaries.

Scans reveal Dolly and her contemporaries had aged normally

Concerns that cloning caused early-onset osteoarthritis (OA) in Dolly the sheep were unfounded, a new study has concluded.

Findings published in the journal Scientific Reports show that Dolly and her contemporaries had aged normally with no clinical signs of OA. Researchers found radiographic evidence of only mild, or in one case, moderate OA.

The results appear to be in stark contrast to reports that led to much debate over the possibility of early-onset disease in cloned animals.

Professor Kevin Sinclair, one of the team members that carried out the research, said: “Our findings of last year appeared to be at odds with original concerns surrounding the nature and extent of osteoarthritis in Dolly – who was perceived to have aged prematurely.

“Yet no formal, comprehensive assessment of osteoarthritis in Dolly was ever undertaken. We, therefore, felt it necessary to set the record straight.”

Dolly was one of the first animals to be cloned from adult cells, attracting considerable scientific and media attention across the world. In 2003, reports emerged that Dolly was suffering from osteoarthritis at the age of five - a disease which is normally found in older sheep.

The only formal record of OA in Dolly is a brief mention in an abstract report. In absence of the original clinical records, a team of researchers from the Universities of Nottingham and Glasgow set out to see whether the concerns were justified.

They travelled to Edinburgh, where the skeletons of Dolly, Bonnie (her naturally-conceived daughter) and Megan and Morag (the first two animals to be cloned from differentiated cells) are kept. They performed a radiographic assessment on the skeletons and then compared them with x-rays of sheep that had been naturally conceived.

“We found that the prevalence and distribution of radiographic-OA was similar to that observed in naturally conceived sheep, and our healthy aged cloned sheep,” said Professor Sandra Corr, who was part of the investigation team. “As a result, we conclude that the original concerns that cloning had caused early-onset OA in Dolly were unfounded.”

Image (C) University of Nottingham.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.